Compound ID | 2667
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris, and Klebsiella pneumoniae |
| Description: | Natural product from Streptomyces lividoclavatus; low toxicity observed in mice (LD50 600 mg/kg); shows growth-promoting activity observed in broiler and pigs; protects mice from Staphylococcus infection when administered subcutaneously; contains a phosphoglycolipid scaffold |
| Institute where first reported: | Central Research Laboratories, Sankyo Co., Ltd. 2-58, 1-chome, Hiromachi, Shinagawa-ku, Tokyo 140, Japan |
| Year first mentioned: | 1977 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/139589144 |
| Citation: | https://www.jstage.jst.go.jp/article/antibiotics1968/30/12/30_12_1060/_pdf/-char/en |